Miniatura

Fitxers

jcm-10-04678-v2.pdf (270.24 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-10-13

Llicència de publicació

cc-by (c) Muñoz-Gómez, Ana et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/181361

Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3390/jcm10204678

Resum

We aimed to determine the impact of steroid use in COVID-19 in-hospital mortality, in a retrospective cohort study of the SEMICOVID19 database of admitted patients with SARS-CoV-2 laboratory-confirmed pneumonia from 131 Spanish hospitals. Patients treated with corticosteroids were compared to patients not treated with corticosteroids; and adjusted using a propensity-score for steroid treatment. From March-July 2020, 5.262 (35.26%) were treated with corticosteroids and 9.659 (64.73%) were not. In-hospital mortality overall was 20.50%; it was higher in patients treated with corticosteroids than in controls (28.5% versus 16.2%, OR 2.068 [95% confidence interval; 1.908 to 2.242]; p = 0.0001); however, when adjusting by occurrence of ARDS, mortality was significantly lower in the steroid group (43.4% versus 57.6%; OR 0.564 [95% confidence interval; 0.503 to 0.633]; p = 0.0001). Moreover, the greater the respiratory failure, the greater the impact on mortality of the steroid treatment. When adjusting these results including the propensity score as a covariate, in-hospital mortality remained significantly lower in the steroid group (OR 0.774 [0.660 to 0.907], p = 0.002). Steroid treatment reduced mortality by 24% relative to no steroid treatment (RRR 0.24). These results support the use of glucocorticoids in COVID-19 in this subgroup of patients.

Matèries

COVID-19, Cortisona, Mortalitat

Matèries (anglès)

COVID-19, Cortisone, Mortality

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MUÑOZ GÓMEZ, Ana, FERNÁNDEZ CRUZ, Ana, LAVILLA OLLEROS, Cristina, GINER GALVAÑ, Vicente, AUSÍN GARCÍA, Cristina, WIKMAN, Philip, BENDALA ESTRADA, Alejandro david, VARGAS NÚÑEZ, Juan antonio, RUBIO RIVAS, Manuel, LAUREIRO, Jaime, FERNÁNDEZ BERMÚDEZ, Daniel, BUONAIUTO, Verónica a., ARENAS DE LARRIVA, Antonio p., PASCUAL PÉREZ, Maria de los reyes, ALCALÁ PEDRAJAS, José nicolás, LABIRUA-ITURBURU RUIZ, Ane, HERNÁNDEZ MILIÁN, Almudena, GÓMEZ DEL MAZO, Marta, ANTEQUERA, Beatriz, MELLA PÉREZ, Carmen, NAVAS ALCÁNTARA, María, SOTO DELGADO, Juan f., GÁMEZ MANCERA, Rosa m., SARDIÑA GONZÁLEZ, Cristina, MEIJIDE MÍGUEZ, Héctor, RAMOS-RINCÓN, José manuel, GÓMEZ HUELGAS, Ricardo, On Behalf of the SEMI-COVID-19 Network. Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study. _Journal of Clinical Medicine_. 2021. Vol. 10, núm. 20, pàgs. 4678. [consulta: 31 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/181361]

Exportar metadades

JSON - METS

Compartir registre